2/4
09:11 pm
abt
?????????????????????????????????????2035????38???????????????????????????(CAGR)?6.11%?????????? [CNET News]
Low
Report
?????????????????????????????????????2035????38???????????????????????????(CAGR)?6.11%?????????? [CNET News]
2/4
06:42 pm
abt
Check Your CGM: Recalled FreeStyle Libre 3 Sensors Associated With 7 Deaths [CNET News]
Low
Report
Check Your CGM: Recalled FreeStyle Libre 3 Sensors Associated With 7 Deaths [CNET News]
2/4
02:44 pm
abt
Do Wall Street Analysts Like Abbott Laboratories Stock? [Yahoo! Finance]
Low
Report
Do Wall Street Analysts Like Abbott Laboratories Stock? [Yahoo! Finance]
2/4
08:22 am
abt
AbbVie's (NYSE:ABBV) Q4 CY2025: Beats On Revenue [Yahoo! Finance]
Low
Report
AbbVie's (NYSE:ABBV) Q4 CY2025: Beats On Revenue [Yahoo! Finance]
2/4
06:46 am
abt
Medtronic set to acquire CathWorks for $585m [Yahoo! Finance]
Low
Report
Medtronic set to acquire CathWorks for $585m [Yahoo! Finance]
2/3
09:29 am
abt
Abbott (ABT) Faces Profit Headwinds as Pediatric Nutrition Remains Under Pressure [Yahoo! Finance]
Low
Report
Abbott (ABT) Faces Profit Headwinds as Pediatric Nutrition Remains Under Pressure [Yahoo! Finance]
2/2
10:09 pm
abt
Abbott Labs CEO makes $2M bet as stock sinks [Yahoo! Finance]
Low
Report
Abbott Labs CEO makes $2M bet as stock sinks [Yahoo! Finance]
2/2
08:55 pm
abt
Abbott Laboratories (ABT): A Bull Case Theory [Yahoo! Finance]
Low
Report
Abbott Laboratories (ABT): A Bull Case Theory [Yahoo! Finance]
2/2
05:42 pm
abt
The Best Dividend King to Buy With $150 [Yahoo! Finance]
Low
Report
The Best Dividend King to Buy With $150 [Yahoo! Finance]
2/2
03:38 pm
abt
Abbott's Exact Sciences Deal Recasts Diagnostics While Nutrition Faces Reset [Yahoo! Finance]
Low
Report
Abbott's Exact Sciences Deal Recasts Diagnostics While Nutrition Faces Reset [Yahoo! Finance]
2/2
01:13 pm
abt
NVST or ABT: Which Is the Better Value Stock Right Now? [Yahoo! Finance]
Low
Report
NVST or ABT: Which Is the Better Value Stock Right Now? [Yahoo! Finance]
2/2
09:50 am
abt
Abbott: Long-Term Investment Opportunity For Dividend Growth Investors [Seeking Alpha]
Low
Report
Abbott: Long-Term Investment Opportunity For Dividend Growth Investors [Seeking Alpha]
2/2
09:31 am
abt
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at Barclays PLC from $169.00 to $142.00. They now have an "overweight" rating on the stock.
Low
Report
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at Barclays PLC from $169.00 to $142.00. They now have an "overweight" rating on the stock.
2/1
02:53 am
abt
Freedom Capital Upgrades Abbott Laboratories (ABT) to Buy [Yahoo! Finance]
Low
Report
Freedom Capital Upgrades Abbott Laboratories (ABT) to Buy [Yahoo! Finance]
1/31
09:48 pm
abt
Decent Organic Sales Growth Expected for Abbott Laboratories (ABT) in 2026 [Yahoo! Finance]
Low
Report
Decent Organic Sales Growth Expected for Abbott Laboratories (ABT) in 2026 [Yahoo! Finance]
1/31
07:51 pm
abt
Looking for Passive Income in 2026? 3 Dividend Kings to Buy Hand Over Fist [Yahoo! Finance]
Low
Report
Looking for Passive Income in 2026? 3 Dividend Kings to Buy Hand Over Fist [Yahoo! Finance]
1/31
07:03 pm
abt
Abbott Laboratories Resets Portfolio With Exact Sciences Cancer Diagnostics Deal [Yahoo! Finance]
Low
Report
Abbott Laboratories Resets Portfolio With Exact Sciences Cancer Diagnostics Deal [Yahoo! Finance]
1/31
09:27 am
abt
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at Leerink Partners from $136.00 to $119.00. They now have a "market perform" rating on the stock.
Low
Report
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at Leerink Partners from $136.00 to $119.00. They now have a "market perform" rating on the stock.
1/31
09:27 am
abt
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at Daiwa Capital Markets from $136.00 to $113.00. They now have an "outperform" rating on the stock.
Low
Report
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at Daiwa Capital Markets from $136.00 to $113.00. They now have an "outperform" rating on the stock.
1/31
07:45 am
abt
Abbott Laboratories (NYSE:ABT) was upgraded by analysts at Freedom Capital from a "hold" rating to a "strong-buy" rating.
Low
Report
Abbott Laboratories (NYSE:ABT) was upgraded by analysts at Freedom Capital from a "hold" rating to a "strong-buy" rating.
1/29
05:31 pm
abt
Abbot (ABT) is a High Quality Company, Says Jim Cramer [Yahoo! Finance]
Medium
Report
Abbot (ABT) is a High Quality Company, Says Jim Cramer [Yahoo! Finance]
1/28
09:33 am
abt
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at Argus from $150.00 to $140.00.
Low
Report
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at Argus from $150.00 to $140.00.
1/27
10:24 pm
abt
What To Expect From Stryker's (SYK) Q4 Earnings [Yahoo! Finance]
Low
Report
What To Expect From Stryker's (SYK) Q4 Earnings [Yahoo! Finance]
1/27
05:12 pm
abt
Abbott Laboratories (NYSE:ABT) was downgraded by analysts at
Weiss Ratings from a "buy (b-)" rating to a "hold (c+)" rating.
Low
Report
Abbott Laboratories (NYSE:ABT) was downgraded by analysts at
Weiss Ratings from a "buy (b-)" rating to a "hold (c+)" rating.
1/27
06:26 am
abt
Optimism around Abbott Laboratories (NYSE:ABT) delivering new earnings growth may be shrinking as stock declines 11% this past week [Yahoo! Finance]
Low
Report
Optimism around Abbott Laboratories (NYSE:ABT) delivering new earnings growth may be shrinking as stock declines 11% this past week [Yahoo! Finance]